Infection of the subcutis of the nose in a cat caused by Mucor species: successful treatment using posaconazole

Journal of Feline Medicine and Surgery

Volumn 10, Issue 5, 2008, Pages 523-527

  Wray, Jonathan D ^a   Sparkes, Andrew H ^a   Johnson, Elizabeth M ^b  

^a ANIMAL HEALTH TRUST   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; POSACONAZOLE; TRIAZOLE DERIVATIVE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CASE REPORT; CAT; CAT DISEASE; DRUG EFFECT; FEMALE; MUCOR; MUCORMYCOSIS; TREATMENT OUTCOME;

ANIMALS; ANTIBIOTICS, ANTIFUNGAL; CAT DISEASES; CATS; FEMALE; MUCOR; MUCORMYCOSIS; TREATMENT OUTCOME; TRIAZOLES;

MUCOR;

EID: 51449103842     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfms.2008.06.001     Document Type: Article

References (26)

1. Bouza E., Munoz P., and Guinea J. Mucormycosis: an emerging disease?. Clinical Microbiology and Infection 12 suppl 7 (2006) 7-23
2. Chandrasekar P. Selection criteria for antifungals: the right patients and the right reasons. International Journal of Antimicrobial Agents 27 suppl 1 (2006) 17-20
3. Chayakulkeeree M., Ghannoum M.A., and Perfect J.R. Zygomycosis: the re-emerging fungal infection. European Journal of Clinical Microbiology and Infectious Disease 25 (2006) 215-229
4. Commonwealth Advisory Bureaux (CABI) Index Fungorum. Available from: .
5. Connolly J.H., Canfield P.J., and Obendorf D.L. Gross, histological and immunohistochemical features of mucormycosis in the platypus. Journal of Comparative Pathology 123 (2000) 36-46
6. Flagothier C., Arrese J.E., Quatresooz P., and Piérard G.E. General review: cutaneous mucormycosis. Journal de Mycologie Médicale 16 (2006) 77-81
7. Glo{combining double acute accent}ckner A., Vehreschild J.J., and Cornely O.A. Zygomycosis -current epidemiological aspects. Mycoses 50 suppl 1 (2007) 50-55
8. Groll A.H., and Walsh T.J. Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections. Mycoses 49 suppl 1 (2006) 7-16
9. Hargis A.M., Ginn P.E., Mansell J., and Garber R.L. Ulcerative facial and nasal dermatitis and stomatitis in cats associated with feline herpesvirus 1. Veterinary Dermatology 10 4 (1999) 267-274
10. Hof H. A new, broad-spectrum azole antifungal: posaconazole - mechanisms of action and resistance, spectrum of activity. Mycoses 49 suppl 1 (2006) 2-6
11. Kauffman C.A. Clinical efficacy of new antifungal agents. Current Opinion in Microbiology 9 (2006) 483-488
12. Kennis R.A., Rosser Jr. E.J., and Dunstan R.W. Difficult dermatologic diagnosis. Journal of the American Veterinary Medical Association 204 (1994) 51-52
13. Khosravi A.R. Fungal flora of the hair coat of stray cats in Iran. Mycoses 39 (1996) 241-243
14. Kontoyiannis D.P., Lionakis M.S., Lewis R.E., Chamilos G., Healy M., Perego C., Safdar A., Kantarjian H., Champlin R., Walsh T.J., and Raad I.I. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. Journal of Infectious Diseases 191 (2005) 1350-1360
15. Malik R., Craig A.J., Wigney D.I., Martin P., and Love D.N. Combination chemotherapy of canine and feline cryptococcosis using subcutaneously administered amphotericin B. Australian Veterinary Journal 73 (1996) 124-128
16. Malik R., Vogelnest L., O'Brien C.R., White J., Hawke C., Wigney D.I., Martin P., and Norris J.M. Infections and some other conditions affecting the skin and subcutis of the naso-ocular region of cats-clinical experience 1987-2003. Journal of Feline Medicine and Surgery 6 (2004) 383-390
17. McKay J.S., Cox C.L., and Foster A.P. Cutaneous alternariosis in a cat. Journal of Small Animal Practice 42 (2001) 75-78
18. McLellan G.J., Aquino S.M., Mason D.R., Kinyon J.M., and Myers R.K. Use of posaconazole in the management of invasive orbital aspergillosis in a cat. Journal of the American Animal Hospital Association 42 (2006) 302-307
19. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi. Approved Standard. NCCLS Document M38-A (2002), National Committee for Clinical Laboratory Standards, Wayne, PA
20. Nomeir A.A., Kumari P., Hilbert M.J., Gupta S., Loebenberg D., Cacciapuoti A., Hare R., Miller G.H., Lin C.C., and Cayen M.N. Pharmacokinetics of SCH 56592, a new azole broad-spectrum antifungal agent, in mice, rats, rabbits, dogs, and cynomolgus monkeys. Antimicrobial Agents and Chemotherapy 44 (2000) 727-731
21. Plumb D.C. Amphotericin B desoxycholate/amphotericin B lipid-based. In: Plumb D.C. (Ed). Plumb's Veterinary Drug Handbook. 5th edn (2005), Blackwell, Iowa 45-50
22. Prabhu R.M., and Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clinical Microbiology and Infection 10 suppl 1 (2004) 31-47
23. Ravisse P., Fromentin H., Destombes P., and Mariat F. Cerebral mucormycosis in the cat caused by Mucor pusillus. Sabouraudia 16 (1978) 291-298
24. Schonmann M., Thoma R., and Braun U. A case of acute disseminated mucor encephalitis in a heifer. Schweizer Archiv für Tierheilkunde 139 (1997) 490-494
25. Tennant K., Patterson-Kane J., Boag A.K., and Rycroft A.N. Nasal mycosis in two cats caused by Alternaria species. Veterinary Record 155 (2004) 368-370
26. Thirion-Delalande C., Guillot J., Jensen H.E., Crespeau F.L., and Bernex F. Disseminated acute concomitant aspergillosis and mucormycosis in a pony. Journal of Veterinary Medicine Series A 52 (2005) 121-124